Corporate venture capital and the nature of innovation

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

  • Hannes Maxin

Organisationseinheiten

Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)1-30
Seitenumfang30
FachzeitschriftEconomics of Innovation and New Technology
Jahrgang29
Ausgabenummer1
Frühes Online-Datum6 Feb. 2019
PublikationsstatusVeröffentlicht - 2020

Abstract

This paper investigates a model where two corporate venture capital firms (CVCs) decide whether to finance a new venture stand-alone or together, called syndication. The CVCs obtain a cash flow if the venture succeeds. In addition, the venture has a positive or negative effect on an asset (e.g. a product or a process) of the CVCs parental companies. This effect may differ among the parental companies. I show that the CVC faced with the weaker positive effect becomes the stand-alone investor only if the cash flow is low. Otherwise, in equilibrium, there are only syndicates or stand-alone investments of the CVC with the stronger positive effect. However, if one CVC faces a positive effect on its parental company's asset whereby the opponent faces a negative effect, then a syndicate is still possible. The model generates empirical predictions for syndicates consisting of several CVCs.

ASJC Scopus Sachgebiete

Zitieren

Corporate venture capital and the nature of innovation. / Maxin, Hannes.
in: Economics of Innovation and New Technology, Jahrgang 29, Nr. 1, 2020, S. 1-30.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Maxin, H 2020, 'Corporate venture capital and the nature of innovation', Economics of Innovation and New Technology, Jg. 29, Nr. 1, S. 1-30. https://doi.org/10.1080/10438599.2019.1571673
Maxin, H. (2020). Corporate venture capital and the nature of innovation. Economics of Innovation and New Technology, 29(1), 1-30. https://doi.org/10.1080/10438599.2019.1571673
Maxin H. Corporate venture capital and the nature of innovation. Economics of Innovation and New Technology. 2020;29(1):1-30. Epub 2019 Feb 6. doi: 10.1080/10438599.2019.1571673
Maxin, Hannes. / Corporate venture capital and the nature of innovation. in: Economics of Innovation and New Technology. 2020 ; Jahrgang 29, Nr. 1. S. 1-30.
Download
@article{8b8d02a9495c493296642b7bb3af3aa2,
title = "Corporate venture capital and the nature of innovation",
abstract = "This paper investigates a model where two corporate venture capital firms (CVCs) decide whether to finance a new venture stand-alone or together, called syndication. The CVCs obtain a cash flow if the venture succeeds. In addition, the venture has a positive or negative effect on an asset (e.g. a product or a process) of the CVCs parental companies. This effect may differ among the parental companies. I show that the CVC faced with the weaker positive effect becomes the stand-alone investor only if the cash flow is low. Otherwise, in equilibrium, there are only syndicates or stand-alone investments of the CVC with the stronger positive effect. However, if one CVC faces a positive effect on its parental company's asset whereby the opponent faces a negative effect, then a syndicate is still possible. The model generates empirical predictions for syndicates consisting of several CVCs.",
keywords = "Corporate venture capital, nature of innovation, nonmonetary support, syndication, venture capital",
author = "Hannes Maxin",
note = "Publisher Copyright: {\textcopyright} 2019, {\textcopyright} 2019 Informa UK Limited, trading as Taylor & Francis Group.",
year = "2020",
doi = "10.1080/10438599.2019.1571673",
language = "English",
volume = "29",
pages = "1--30",
number = "1",

}

Download

TY - JOUR

T1 - Corporate venture capital and the nature of innovation

AU - Maxin, Hannes

N1 - Publisher Copyright: © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.

PY - 2020

Y1 - 2020

N2 - This paper investigates a model where two corporate venture capital firms (CVCs) decide whether to finance a new venture stand-alone or together, called syndication. The CVCs obtain a cash flow if the venture succeeds. In addition, the venture has a positive or negative effect on an asset (e.g. a product or a process) of the CVCs parental companies. This effect may differ among the parental companies. I show that the CVC faced with the weaker positive effect becomes the stand-alone investor only if the cash flow is low. Otherwise, in equilibrium, there are only syndicates or stand-alone investments of the CVC with the stronger positive effect. However, if one CVC faces a positive effect on its parental company's asset whereby the opponent faces a negative effect, then a syndicate is still possible. The model generates empirical predictions for syndicates consisting of several CVCs.

AB - This paper investigates a model where two corporate venture capital firms (CVCs) decide whether to finance a new venture stand-alone or together, called syndication. The CVCs obtain a cash flow if the venture succeeds. In addition, the venture has a positive or negative effect on an asset (e.g. a product or a process) of the CVCs parental companies. This effect may differ among the parental companies. I show that the CVC faced with the weaker positive effect becomes the stand-alone investor only if the cash flow is low. Otherwise, in equilibrium, there are only syndicates or stand-alone investments of the CVC with the stronger positive effect. However, if one CVC faces a positive effect on its parental company's asset whereby the opponent faces a negative effect, then a syndicate is still possible. The model generates empirical predictions for syndicates consisting of several CVCs.

KW - Corporate venture capital

KW - nature of innovation

KW - nonmonetary support

KW - syndication

KW - venture capital

UR - http://www.scopus.com/inward/record.url?scp=85061303677&partnerID=8YFLogxK

U2 - 10.1080/10438599.2019.1571673

DO - 10.1080/10438599.2019.1571673

M3 - Article

AN - SCOPUS:85061303677

VL - 29

SP - 1

EP - 30

JO - Economics of Innovation and New Technology

JF - Economics of Innovation and New Technology

SN - 1043-8599

IS - 1

ER -